5-[4-(2-Hydroxyethoxy)phenyl]-11,12-dihydro-5H-6,13-dioxabenzo[3,4]cyclohepta [1,2-a]naphthalene-2,8-diol

ID: ALA1087683

PubChem CID: 44597969

Max Phase: Preclinical

Molecular Formula: C25H22O6

Molecular Weight: 418.45

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  OCCOc1ccc(C2Oc3cc(O)ccc3C3=C2c2ccc(O)cc2OCC3)cc1

Standard InChI:  InChI=1S/C25H22O6/c26-10-12-29-18-5-1-15(2-6-18)25-24-20(19-7-3-17(28)14-23(19)31-25)9-11-30-22-13-16(27)4-8-21(22)24/h1-8,13-14,25-28H,9-12H2

Standard InChI Key:  ZWJVWQRDPFBRFW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   17.1528   -6.5767    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1517   -7.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8644   -7.8133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8626   -6.1651    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5759   -6.5731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5793   -7.4037    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2964   -7.8138    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0148   -7.3978    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5325   -4.7654    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.0122   -6.5720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2896   -6.1525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.1618   -5.2900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7108   -4.7044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.0235   -5.4206    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7909   -6.2540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3956   -6.8701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2332   -6.6540    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.4627   -5.8164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8564   -5.2040    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3029   -5.5960    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.7280   -7.8075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.7263   -8.6302    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4387   -9.0398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1511   -8.6268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1467   -7.8000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4336   -7.3941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8651   -9.0356    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.5760   -8.6218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2898   -9.0305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4390   -7.8124    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0007   -8.6167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
 14 15  2  0
  5 11  1  0
 15 16  1  0
  6  7  1  0
 16 17  2  0
  7  8  1  0
 17 18  1  0
  8 10  1  0
 18 19  2  0
 19 14  1  0
  5  4  2  0
 18 20  1  0
  4  1  1  0
  8 21  1  0
  5  6  1  0
 21 22  2  0
 22 23  1  0
  2  3  1  0
 23 24  2  0
 14  9  1  0
 24 25  1  0
 15 10  1  0
 25 26  2  0
 26 21  1  0
 11 12  1  0
 24 27  1  0
 12 13  1  0
 27 28  1  0
 13  9  1  0
 28 29  1  0
 10 11  2  0
  2 30  1  0
  3  6  2  0
 29 31  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA1087683

   19-[4-(2-Hydroxyethoxy)phenyl]-8,18-dioxatetracyclo[9.8.0.02,7.012,17]nonadeca-1(11),2(7),3,5,12(17),13,15-heptaene-5,15-diol

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 418.45

Molecular Weight (Monoisotopic): 418.1416

AlogP: 4.30

#Rotatable Bonds: 4

Polar Surface Area: 88.38

Molecular Species: NEUTRAL

HBA: 6

HBD: 3

#RO5 Violations: ┄

HBA (Lipinski): 6

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 8.61

CX Basic pKa: ┄

CX LogP: 3.69

CX LogD: 3.66

Aromatic Rings: 3

Heavy Atoms: 31

QED Weighted: 0.59

Np Likeness Score: 0.63

References

1. Jain N, Xu J, Kanojia RM, Du F, Jian-Zhong G, Pacia E, Lai MT, Musto A, Allan G, Reuman M, Li X, Hahn D, Cousineau M, Peng S, Ritchie D, Russell R, Lundeen S, Sui Z..  (2009)  Identification and structure-activity relationships of chromene-derived selective estrogen receptor modulators for treatment of postmenopausal symptoms.,  52  (23): [PMID:19366247] [10.1021/jm900146e]

Source

Source(1):

• Scientific Literature